Brain oligodendroglioma

Summary

Brain oligodendroglioma (MONDO:0002544) is a disease and 1 clinical trial. A subtype of brain glioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	brain oligodendroglioma
Mondo ID	MONDO:0002544
DOID	DOID:3187
NCIT	C9377
SNOMED CT	254940005
UMLS	C0346286
MedGen	91095
GARD	0023160
Anatomy (UBERON)	UBERON:0000955
Is cancer (heuristic)	no

Also known as: brain oligodendroglioma · oligodendroglioma of brain · oligodendroglioma of the brain

Disease family

This is a subtype of brain glioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › nervous system cancer › central nervous system cancer › brain cancer › brain glioma › brain oligodendroglioma

Related subtypes (7): brain glioblastoma, brain stem glioma, diencephalic astrocytomas, childhood cerebral astrocytoma, ependymal tumor of brain, gliomatosis cerebri, chordoid glioma of the third ventricle

Subtypes (1): corpus callosum oligodendroglioma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
EARLY_PHASE1	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04135807	EARLY_PHASE1	RECRUITING	Implantable Microdevice In Primary Brain Tumors